#cancer surveillance Tech News.
1 story in the last 7 days
The latest cancer surveillance news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks cancer surveillance across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AIThe Next Webabout 2 hours ago
Bios Life exits stealth with $25M and Tempus allianceBios Life emerged from stealth with $25M in seed funding led by Redmile, Vsquared Ventures, and Kindred Capital. The Boston company plans AI-driven continuous cancer surveillance using Tempus data and BioNTech-InstaDeep's Nucleotide Transformer, targeting over 40 million Americans at risk or surviving cancer. Launch is slated for the second half of 2026.
Summaries by ByteBrief